Shopping Cart (Login required)

Group Management

The Board of Directors has in accordance with its guidelines and instructions assigned to the Company’s CEO, Torben Jørgensen, to manage the Company’s affaires. The CEO, and the Executive Management under the supervision of the CEO, is responsible for the Group’s day to day business and management. The CEO reports by regular intervals to the Board of Directors how the Company’s business perform, financial result and other issues important to the Company. 

Executive Committee

Torben Jorgensen

Torben Jørgensen
President and CEO of Biotage AB

Torben Jørgensen took up the position as President and CEO of Biotage in conjunction with the Annual General Meeting on April 27, 2006. Prior to that Torben Jørgensen was the CEO of the Molecular Imaging company Affibody for four years, before which he held similar positions at Karo Bio and the Danish diagnostic company, DAKO. He is a board member of Atlas Antibodies AB (since 2007). Torben is the Chairman of the Board at Micropos Medical AB. Torben Jørgensen was born in 1952, and has a degree from Copenhagen Business School.

.

 

 

Erika Söderberg Johnson
Chief Financial Officer

Erika Söderberg Johnson is Chief Financial Officer of Biotage since January 2012.  Mrs. Söderberg Johnson has previously been Chief Financial Officer at Karo Bio (2007-2011), Affibody (2005-2007) and Global Genomics (2002-2005). Prior to this, Mrs. Söderberg Johnson spent ten years in Investment Banking and Corporate Finance at SEB Enskilda. She is a board member of publicly listed companies Sectra AB (since 2007), active in the areas of medical IT and secure communication, and MedCap AB (since 2014), an industrial investor in Life Science companies. Mrs. Söderberg Johnson was born in 1970, and has a M. Sc. BA from Stockholm School of Economics.

 

Lars Bäckman
VP of Corporate Development

Lars Bäckman has been with Biotage since January 2007 as the VP of Corporate Development. Prior joining Biotage, Lars Bäckman held the position as SVP of Corporate Development at Affibody. He has previous experiences acting as a lawyer at the Swedish law firm Hamilton & Co, specialized in Corporate Finance and Mergers & Acquisitions, and from Venture Management at the Business Development firm Googol. He is the Chairman of the Board in Chreto ApS. Mr. Bäckman holds a LLM from the Stockholm University and was born in 1961.